[2P-1062（2AT26-12）] Identification of novel autism biomarkers by secretome analysis using click sugars

〇Ryota Nagatomo¹, Yousuke Nao¹, Misaki Kimura¹, Genta Ito¹, Sho Takatori¹, Taisuke Tomita¹ (1.Lab. of Neuropath. and Neurosci., Grad. Sch. of Pharm. Sci., Univ. of Tokyo)

ConBio2017

[2P-1063（2AT26-13）] Novel Drosophila model for autism spectrum disorder targeting of ATP-binding cassette protein A

〇Ibuki Ueoka¹, Hitoshi Kawashima ², Atsushi Konishi², Mikio Aoki², Ryo Tanaka¹, Hideki Yoshida¹, Toru Maeda³, Mamiko Ozaki³, Masamitu Yamaguchi¹ (1.Dept. of Apple. Bio., Kyoto Inst. of Technology, 2.Sumitomo Dainippon Pharma Co., Ltd, 3.Dept. of Bio., Univ. of Kobe)

ConBio2017

[2P-1064（2AT26-15）] Plasma cytokines levels in depression patients and in animal model of depression after stress.

Kenki Morimoto¹, Emiko Kasahara¹, Shiho Ito¹, Mizuki Takenaka¹, Masato Murayama¹, Mika Hori¹, 〇Atsuo Sekiyama¹ (1.Dept. of Preem. Med. Pharma., Grad. Sch. of Pharma., Univ. of Osaka)

ConBio2017

[2P-1065] Natural (Δ-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through cannabinoid CB1 receptor

〇Olga Malyshevskaya¹, Kosuke Aritake^1,2, Mahesh K. Kaushik¹, Nahoko Uchiyama³, Yoan Cherasse¹, Ruri Kikura-Hanajiri³, Yoshihiro Urade¹ (1.International Institute for Integrative Sleep International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 2.Daiichi University of Pharmacy, 3.Division of Pharmacognosy, Phytochemistry, and Narcotics, National Institute of Health Sciences)

ConBio2017

[2P-1066] Protective property of p3-Alcβ against a neurotoxicity induced by Aβ oligomer

〇Haruka Saito¹, Chiori Omori¹, Ayano Kimura¹, Masaaki Waragai², Masahiro Maeda³, Saori Hata¹, Toshiharu Suzuki¹ (1.Univ. of Hokkaido, 2.Higashimatsudo Hsp., 3.IBL Co., Ltd.)

ConBio2017

[2P-1067] Transcriptional regulation of ILEI/FAM3C gene in neuronal and non-neuronal cells

〇Naoki Watanabe¹, Wataru Shoji¹, Akihiro Kawatsuki¹, Emi Hibino¹, Rei Nomura¹, Masaki Nishimura¹ (1.Mol. Neurosci. Res. Ctr., Shiga Univ. of Med. Sci.)

ConBio2017

[2P-1068] Establishment and characterization of a Parkinsonʼs disease model mice

〇Megumi Hiraishi^1,2, Fumika Koyano¹, Shin-ichi Hisanaga², Kazuto Nakada³, Keiji Tanaka^1,4, Noriyuki Matsuda¹ (1.Ubiquitin Project, TMIMS, 2.Tokyo Metro.Univ., 3.The Univ. of Tsukuba, 4.Lab of Protein Metabolism, TMIMS)

ConBio2017

[2P-1069] Transcriptional analysis of neuronal model of ASD-associated CNV

〇Hiroaki Mutsumine^1,2, Amila Zuko², Tsukasa Kouno³, Jay Shin³, Pierro Carninci³, Hidemi Misawa¹, Jun Nomura², Toru Takumi² (1.Dept. of Pha. Sci., Grad. Sch. of Pha., Keio Univ., 2.BSI, RIKEN, 3.CLST, RIKEN)

ConBio2017

[2P-1070] Brain micro-inflammation at specific vessels creates new neural pathways, which induces the gastrointestinal failure under stress conditions

〇Yasunobu Arima¹, Takuto Ohki¹, Naoki Nishikawa¹, Kotaro Higuchi¹, Stofkova Andrea¹, Akihiko Yoshimura², Daisuke Kamimura¹, Masaaki Murakami¹ (1.Div.of Psychoimmunol, IGM, Grad. Sch. of Med, Hokkaido Univ , 2.Dept. of Microbiology and Immunology, Grad. Sch. of Med, Keio Univ)

ConBio2017

[2P-1071] Visualization of neurological disease-associated repeat RNA using fluorescent aptamers

〇Yoshihiro Kino¹, Yasuyuki Masaki¹, Mika Takitani¹, Jun-ichi Satoh¹ (1.Dept. of Bioinfo, Meiji Pharm. Univ.)

ConBio2017